TrialAntimicrobial agents and chemotherapy2008

First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.

Johannes Nagelschmitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.